New drug tested in people with liver disease
NCT ID NCT06957756
First seen Feb 21, 2026 · Last updated Apr 30, 2026 · Updated 11 times
Summary
This study looks at how different levels of liver problems (mild, moderate, severe) affect the way the body handles a single dose of the experimental drug BI 1584862. It includes 44 adults aged 18-80, both with and without liver issues, to compare results. Participants take the drug once and are monitored for about 5 weeks with blood tests and health checks.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC INSUFFICIENCY are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
American Research Corporation
RECRUITINGSan Antonio, Texas, 78215, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Arizona Clinical Trials - Chandler
RECRUITINGChandler, Arizona, 85225, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Omega Research Orlando, LLC
RECRUITINGOrlando, Florida, 32808, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.